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Abstract: Rickettsia felis bacterium has been observed since the
early twentieth century in the cat ﬂea. It was grown for the ﬁrst
time in my laboratory on cell Xenopus then insect cells particularly
Aedes albopictus cells. It grows only at temperature under 30 ◦C.
First described in California, the bacterium is present in the whole
world. For a long time it was considered a rare disease associated
with ﬂeas. In fact, in recent years, Rickettsia felis was found as the
most frequently identiﬁed bacteria in patients with fever in trop-
ical countries after malaria. These data were conﬁrmed in West
Africa and East Africa by different teams. Rickettsia felis has also
been detected in tropical and tropical areas of South America, Asia
andOceania. Rickettsia felis and is themost common rickettsial cur-
rently in the world and very frequently associated with fever in
the tropics and cough but no rash. In contrast controls without
fever, can cause at a lower but signiﬁcant level, the presence of
Rickettsia felis DNA. So these circulations of Rickettsia felis in the
blood that are not always associated with fever. Possible vectors in
tropical areas may be mosquitoes in Africa. Rickettsia felis has the
same epidemiological distribution as malaria. Rickettsia felis was
found in Anopheles species and Aedes albopictus. A mouse experi-
mentalmodelwas established showing that Rickettsia felis could be
vectorized by Anopheles gambiae. Rickettsia felis, ﬁnally, recently,
was found in book lice in the dust, which further complicates the
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Background: In India, control of rabies in dogs by massvaccina-
tion is the practical approach. Currently, viable infectious Rabies
virus (RABV) dependent and laborious Rapid Fluorescent Focus
Inhibition Test (RFFIT) is employed in selected laboratories in India
tomonitor the vaccinal antibodies. This situationdemands an alter-
native rapid, sensitive, speciﬁc and user friendly test. Hence, this
study was undertaken to express the recombinant glycoprotein
(rRVL-G) of Dr. Larghi’s strain of RABV and evaluate it’s diagnostic
potential.
Methods & Materials: The RABV propagated in BHK 21 cells
was used as the source of G gene. The Polymerase Chain Reac-
tion (PCR) product of G-genewas cloned into pGEM®-T Easy Vector
and transferred into competent Top 10 E. coli. The insert from the
recombinants (pGRVL-G) was subcloned into pET32a vector, trans-
ferred into TOP 10 cells and recombinants (pETRVL-G) obtained.
These recombinants were transferred into E.coli BL21 and screened
for expression and immunogenicity by SDS-PAGE and Western
Blotting respectively. Indirect ELISA was standardized by Checker-
board titration of complete RABV-G protein (RV-G) and diagnostic
potentials of rRVL-G conﬁrmed.
Results: The PCR product of RABV complete G gene revealed a
band of 1596 bp. The PCR product cloned in pGEM®-T Easy Vec-
tor and subbcloned in pET32a vector was conﬁrmed by Restriction
Enzyme (RE) digestion and colony PCR (Fig. 1a, 1b) and sequencing.
Further SDS-PAGE of the IPTG induced clones revealed a fusionpro-
tein of 75kDawhichwas conﬁrmed tobe immunogenic byWestern
blotting (Fig. 2a, 2b)whenprobedwith anti rabies vaccinal dog sera.
Standardization of indirect ELISA and application using RV-G and
rRVL-Gby testingof 40anti rabies vaccinal dog sera of varyingRFFIT
titres revealed a signiﬁcant correlation in the performance of both
the antigens (Fig. 3a, 3b).
Conclusion: The outcome of the work suggested the diagnostic
potentials of the recombinant protein in ELISA for seromonitoring
of antirabies vaccinal antibodies. In view of the availability of ELISA
facilities, expertise and limitations of RFFIT in India, the results
encourage the development of recombinant G-protein based ELISA
as a newer diagnostics for sero monitoring of antirabies vaccinal
antibodies in both domestic and street dogs at a regular interval of
time.
http://dx.doi.org/10.1016/j.ijid.2016.02.075
